Impax Labs (IPXL) Tops Q3 EPS by 2c

Impax Labs (NASDAQ: IPXL) reported Q3 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $158 million versus the consensus estimate of $148.36 million.

For earnings history and earnings-related data on Impax Labs (IPXL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Vireo Growth completes acquisition of C21 Investments
• BMO starts chip stocks coverage: Here are its preferred picks